Search results
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle -...
Benzinga· 7 days agoCanadian Biotech company Acuitas Therapeutics and Germany-based CureVac NV CVAC have settled...
Unable to work since COVID vaccination, Gatineau man pins hopes on compensation
CBC via Yahoo News· 4 days agoA Gatineau, Que., man who developed a debilitating skin ailment after receiving a COVID-19 vaccine...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 2 days agoExcluding that, Paxlovid sales still topped expectations. Comirnaty, the Covid vaccine Pfizer...
Why Africa is facing an uphill battle to make its own vaccines
The Telegraph via Yahoo News· 2 days agoIt simply wasn’t affordable for the plans for a new plant to go ahead – something experts have...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 2 days ago, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter profit...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
GuruFocus.com via Yahoo Finance· 19 hours agoLitigation and Intellectual Property Updates Arbutus continues to defend its intellectual property vigorously, particularly in ongoing litigation with Moderna and Pfizer/BioNTech< ...
The CDC Took Out 148 Pages of Essential Information
Mercola· 8 hours agoPeople who receive a COVID-19 shot are at increased risk of myocarditis, or inflammation of the heart muscle,1 and pericarditis, which is inflammation of the outer lining of the heart. The public ...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga· 13 hours agoThursday, Moderna Inc MRNA reported a first-quarter EPS loss of $(3.07), down from an income of...
TIME100 Health: Katalin Kariko and Drew Weissman
Time Magazine· 20 hours agoDr. Drew Weissman was working on developing an HIV vaccine, and Katalin Kariko was struggling to keep her lab open and convince her superiors that her...